Viking Therapeutics
VKTX
VKTX
390 hedge funds and large institutions have $2.02B invested in Viking Therapeutics in 2025 Q2 according to their latest regulatory filings, with 84 funds opening new positions, 147 increasing their positions, 108 reducing their positions, and 59 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
10% more capital invested
Capital invested by funds: $1.84B → $2.02B (+$179M)
6% more funds holding
Funds holding: 369 → 390 (+21)
0.06% less ownership
Funds ownership: 67.87% → 67.81% (-0.06%)
Holders
390
Holding in Top 10
2
Calls
$231M
Puts
$97.6M
Top Buyers
| 1 | +$33.4M | |
| 2 | +$28.9M | |
| 3 | +$18.3M | |
| 4 |
Citigroup
New York
|
+$16.5M |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$15.8M |
Top Sellers
| 1 | -$39.8M | |
| 2 | -$37.8M | |
| 3 | -$26.9M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$20.6M |
| 5 |
BlackRock
New York
|
-$14.3M |
